Literature DB >> 24321818

Drug-resistant tuberculosis: latest advances.

Dennis Falzon1, Karin Weyer, Mario C Raviglione.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 24321818     DOI： 10.1016/S2213-2600(12)70056-5

Source DB:  PubMed          Journal:  Lancet Respir Med        ISSN： 2213-2600            Impact factor:   30.700


× No keyword cloud information.
  3 in total

1.  Effect of bacillus Calmette-Guérin vaccination on CD4+Foxp3+ T cells during acquired immune response to Mycobacterium tuberculosis infection.

Authors:  Marcela I Henao-Tamayo; Andres Obregón-Henao; Kimberly Arnett; Crystal A Shanley; Brendan Podell; Ian M Orme; Diane J Ordway
Journal:  J Leukoc Biol       Date:  2015-11-20       Impact factor: 4.962

2.  The Efficacy of the BCG Vaccine against Newly Emerging Clinical Strains of Mycobacterium tuberculosis.

Authors:  Marcela Henao-Tamayo; Crystal A Shanley; Deepshikha Verma; Andrew Zilavy; Margaret C Stapleton; Synthia K Furney; Brendan Podell; Ian M Orme
Journal:  PLoS One       Date:  2015-09-14       Impact factor: 3.240

3.  Safety, immunogenicity, and efficacy of the candidate tuberculosis vaccine MVA85A in healthy adults infected with HIV-1: a randomised, placebo-controlled, phase 2 trial.

Authors:  Birahim Pierre Ndiaye; Friedrich Thienemann; Martin Ota; Bernard S Landry; Makhtar Camara; Siry Dièye; Tandakha Ndiaye Dieye; Hanif Esmail; Rene Goliath; Kris Huygen; Vanessa January; Ibrahima Ndiaye; Tolu Oni; Michael Raine; Marta Romano; Iman Satti; Sharon Sutton; Aminata Thiam; Katalin A Wilkinson; Souleymane Mboup; Robert J Wilkinson; Helen McShane
Journal:  Lancet Respir Med       Date:  2015-02-26       Impact factor: 102.642
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.